| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 07/24/2008 | US20080177071 Process for the preparation of 2- (2- (4- (bis (4-flourophenyl) methyl) -pipe razin-1-yl) ethoxy acetic acid derivatives or corresponding salt forms thereof and intermediates therefor |
| 07/24/2008 | US20080176959 Biodegradable polyphosphates complex for controlled release of bioactive substances and related methods |
| 07/24/2008 | US20080176955 Combined administration of benzonatate and guaifenesin |
| 07/24/2008 | US20080176944 Elongase Genes and Uses Thereof |
| 07/24/2008 | US20080176916 A-amino-n-hydroxy-acetamide derivatives |
| 07/24/2008 | US20080176902 N-{2-[((2S)-3-{[1-(4-chlorobenzyl)piperidin-4-yl]amino}-2-hydroxy-2-methylpropyl)oxy]-4-hydroxyphenyl}acetamide hemifumarate; chemokine receptor 1 modulation; chronic obstructive pulmonary disease, asthma; chemical stability; easy to handle; inhalant formulations |
| 07/24/2008 | US20080176899 Such as 1-Benzo[1,3]dioxol-5-yl-cyclopropanecarboxylic acid [5-(2-methoxy-pyridin-3-ylmethyl)-thiazol-2-yl]-amide 5-(2-Methoxy-pyridin-3-ylmethyl)-thiazol-2-ylamine; cystic fibrosis transmembrane conductance regulator disorders |
| 07/24/2008 | US20080176891 N-(2-Aminoethyl)-4-(2-ethyl-1H-pyrrolo[2,3-b]pyridin-4-yl)benzene-sulfonamide; respiratory disorders; rheumatoid arthritis |
| 07/24/2008 | US20080176841 (amidomethyl-amido)-(carboxy/amido)epoxide derivatives; cathepsin inhibitor; antiinflammatory, anticarcinogenic, antidiabeticagent, antiallergen, autoimmune and neurodegenerative disorders |
| 07/24/2008 | US20080176800 Methods for the delivery of bioactive substances with biodegradable polyphosphates |
| 07/24/2008 | US20080176323 Expression vector comprising nucleotide sequences coding cytokine polypeptide for use in treatment and prevention of lung, viral, cell proliferative and inflammatory diseases |
| 07/24/2008 | US20080175914 Inflammatory and/or allergic diseases; cognitive impairment |
| 07/24/2008 | US20080175899 Formulation for promoting sinus health in nasal cavities |
| 07/24/2008 | US20080175887 Treatment of Asthma and Chronic Obstructive Pulmonary Disease With Anti-proliferate and Anti-inflammatory Drugs |
| 07/24/2008 | US20080175841 Antagonistic Anti-hTNFSF13b Human Antibodies |
| 07/24/2008 | US20080175797 Preventing airway mucus production by administration of egf-r antagonists |
| 07/24/2008 | US20080175795 e.g. 3-{4-[4-(2-amino-2-carbamoyl-ethyl)-phenoxy]-phenyl)-propionic acid; antiinflammatory and immunological diseases, cytokines (TNF- alpha , IL-1, IL-6), orexin, nitric oxide synthase inhibitor; obesity, hyperlipidemia, migraine, asthma, chronic obstructive pulmonary disease, osteoarthritis |
| 07/24/2008 | US20080175794 Substituted Pyridazinyl- and Pyrimidinyl-Quinolin-4-Ylamine Analogues |
| 07/23/2008 | EP1947178A1 Human monoclonal antibody binding to human gm-csf and antigen-binding site thereof |
| 07/23/2008 | EP1946776A1 Stabilized TNFR-Fc composition comprising arginine |
| 07/23/2008 | EP1946764A1 Nutrient composition |
| 07/23/2008 | EP1946749A1 Anti-angionene compositions and methods of use |
| 07/23/2008 | EP1945632A1 Heterocyclic modulators of atp-binding cassette transporters |
| 07/23/2008 | EP1945613A1 Novel 1 -benzyl-4-piperidinamines that are useful in the treatment of copd and asthma |
| 07/23/2008 | EP1945226A2 Drug composition with analgesic, anti-inflammatory and decongestive activity |
| 07/23/2008 | EP1945218A2 Use of soluble guanylate cyclase activators for treating acute and chronic lung diseases |
| 07/23/2008 | EP1945210A1 Use of a composition comprising an antacid, a mucolytic an a gelling agent in the treatment of cold |
| 07/23/2008 | EP1675823B1 Phenethanolamine derivatives for the treatment of respiratory diseases |
| 07/23/2008 | EP1603565B1 Medicament comprising a highly potent long-lasting beta2-agonist in combination with other active ingredients |
| 07/23/2008 | EP1523988B1 Composition comprising radix codonopsis pilosulae and radix astragali for the treatment of acute lung injury |
| 07/23/2008 | EP1490367B1 Imidazopyridine derivatives as kinase inhibitors |
| 07/23/2008 | EP1453743B1 Pharmaceutical product and method with an adsorbent |
| 07/23/2008 | EP1412361B1 Substituted 5,6,6a,11b-tetrahydro-7-oxa-5-aza-benzo[c]fluorene-6-carboxylic acid derivatives serving as nmda antagonists |
| 07/23/2008 | EP1382603B1 Nitrogenous fused-ring compound having pyrazolyl group as substituent and medicinal composition thereof |
| 07/23/2008 | EP1342723B1 Indole derivatives and use thereof in medicines |
| 07/23/2008 | EP1278829B1 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 07/23/2008 | EP1270595B1 Anti ccr4 antibody and its fragment |
| 07/23/2008 | EP1218369B1 INHIBITORS OF c-JUN N-TERMINAL KINASES (JNK) AND OTHER PROTEIN KINASES |
| 07/23/2008 | EP1123383B1 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 07/23/2008 | EP1071680B1 N,n-disubstituted amides that inhibit the binding of integrins to their receptors |
| 07/23/2008 | CN101227905A Process for preparing tiotropium salts, tiotropium salts as such and pharmaceutical compositions thereof |
| 07/23/2008 | CN101225398A Technology for preparing active t-PA by procaryotic cells |
| 07/23/2008 | CN101224277A Sticking membrane for mucous membrane after septoplasty |
| 07/23/2008 | CN101224276A Chinese patent medicine for treating rhinitis |
| 07/23/2008 | CN101224273A Preparing method of Jiaozhi soft capsule |
| 07/23/2008 | CN101224259A Quality controlling method of compound south isatis root granules |
| 07/23/2008 | CN101224244A Children clearing heat suppository and preparing method thereof |
| 07/23/2008 | CN101224230A Chinese traditional medicine compounds for treating respiratory tract and throat disease, and preparing method |
| 07/23/2008 | CN101224222A Cydiodine buccal tablet and preparing method thereof |
| 07/23/2008 | CN101224196A Ambroxol hydrochloride freeze-dried powder injection and preparing method thereof |
| 07/23/2008 | CN101224037A Preparing method of tobacco shred additives with tobacco poison-removing and healthy treatment efficacy |
| 07/23/2008 | CN100405062C Therapeutic and diagnostic uses of antibody specificity profiles |
| 07/23/2008 | CN100404669C Novel reovirus, its antibody and vaccine and use thereof |
| 07/23/2008 | CN100404533C New quinuclidine amide derivatives |
| 07/23/2008 | CN100404517C Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof |
| 07/23/2008 | CN100404514C 2-substituted phenyl-4,4,5,5-tetramethyl-1,3,-dioxy imidazolines, their preparation and pharmaceutical use |
| 07/23/2008 | CN100404505C Novel substituted indoles |
| 07/23/2008 | CN100404071C Medicinal composition |
| 07/23/2008 | CN100404067C Traditional medicine preparation for treating children's pulmonary disease |
| 07/23/2008 | CN100404061C Chinese medicinal composition for treating chronic pharygitis |
| 07/23/2008 | CN100404060C Method for preparing 10-component tablets for cough |
| 07/23/2008 | CN100404037C Chinese ephedra and earthworm composition for treating cough and gasp, and its preparation method |
| 07/23/2008 | CN100404031C Soft capsule composition containing zine gluconate, Ibuprofen and chlorphenamine maleate |
| 07/23/2008 | CN100404030C Application of leflunomide in the preparation process of anti SARS virus medicine |
| 07/23/2008 | CN100404026C Oral medicinal composition containing fudosteine |
| 07/22/2008 | US7402682 affinity for peripheral-type benzodiazepine receptors; in vitro and in vivo affinity; chemical intermediates |
| 07/22/2008 | US7402657 C-C chemokine receptor 3 proteins |
| 07/22/2008 | US7402609 Olopatadine formulations for topical administration |
| 07/22/2008 | US7402605 E.g., 17,17-propano-16-hydroxy-5-(4-ethoxycarbonylthiazol-2-yl)-9-oxo-1,2,3,4,20-pentanor-5-thia-8-azaprost-13-ene; EP2 and/or EP4 receptor agonist; immune disease; antiallergens; alopecia; dysmenorrhea; erectile dysfuncction; antiarthritic agents; liver, respiratory, vascular, urogenital disorder |
| 07/22/2008 | US7402600 Nitroderivatives of cardiovascular agents |
| 07/22/2008 | US7402598 Arylethanolamine β2-adrenoreceptor agonist compounds |
| 07/22/2008 | US7402595 JNK inhibitor |
| 07/22/2008 | US7402581 3,5-Dibromo-N-[(2S)-2-(4-fluorophenyl)-4-(3-morpholin-4-ylazetidin-1-yl)butyl]-N-methylbenzamide; neurokinin 1 and 2 (NK1,2) receptors, antagonist; improved pharmacokinetics: not inhibit liver enzyme cytochrome P450, prevent drug-drug interactions, oral bioavailability, antiinflammatory and analgesic |
| 07/22/2008 | US7402572 Suppressing a symptom of an allergic response using nucleic acids containing unmethylated CpG dinucleotides |
| 07/22/2008 | US7402305 Comprises nucleotide sequences coding protein with antiproliferative and viricidal activity for use in treatment and prevention of cancer, nervous system, bone and autoimmune disorders |
| 07/22/2008 | US7402299 Intracorporeal medicaments for photodynamic treatment of disease |
| 07/22/2008 | CA2417825C 6.alpha., 9.alpha.-difluoro-17.alpha.-`(2-furanylcarboxyl)oxy!-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent |
| 07/22/2008 | CA2396145C Osmotic device containing pseudoephedrine and an h1 antagonist |
| 07/22/2008 | CA2372840C Substituted bicyclic compounds |
| 07/22/2008 | CA2366922C Formulations for detecting asthma |
| 07/17/2008 | WO2008086395A2 Anti-il-13 antibody formulations and uses thereof |
| 07/17/2008 | WO2008085913A1 Methods for treating, preventing, or reducing the risk of opthalmic, otic, and nasal infections |
| 07/17/2008 | WO2008085875A2 R-zileuton for use in conditions associated with increased 5-lipoxygenase and/or leukotriene activity (eg asthma) |
| 07/17/2008 | WO2008085608A1 Compounds and compositions as channel activating protease inhibitors |
| 07/17/2008 | WO2008085392A1 Methods for treating nasal congestion in hepatically impaired patients |
| 07/17/2008 | WO2008084312A2 Micronised particles of low-dosage strength active agents for powder formulations for inhalation |
| 07/17/2008 | WO2008084240A1 Chemical compounds 636 : pyridopyrimidinediones as pde4 inhibitors |
| 07/17/2008 | WO2008084236A1 Chemical compounds 635 : pyridopyrimidinediones as pde4 inhibitors |
| 07/17/2008 | WO2008084223A2 Chemical compounds 637: pyridopyrimidinediones as pde4 inhibitors |
| 07/17/2008 | WO2008084004A1 Sulfonamide derivatives as chymase inhibitors |
| 07/17/2008 | WO2008083942A1 Use of sodium blockers for an early therapy of obstructive lung diseases |
| 07/17/2008 | WO2008063957A3 Cblb for treating endotoxin-mediated disorders |
| 07/17/2008 | WO2008029349A3 Muscarinic receptor antagonists |
| 07/17/2008 | WO2007101264A3 Method for treating endothelial and epithelial cell disorders by administering high molecular weight peg-like compounds |
| 07/17/2008 | US20080172751 Agent Comprising Fgf2 as an Effective Ingredient For Treatment or Prevention of Asthma and Chronic Obstructive Pulmonary Disease |
| 07/17/2008 | US20080171882 [(4S)-4-Methyl-2,5-dioxoimidazolidin-4-yl]methanesulfonyl chloride and [(4R)-4-methyl-2,5-dioxoimidazolidin-4-yl]methanesulfonyl chloride; chemical intermediates for enzyme inhibitors |
| 07/17/2008 | US20080171770 e.g. 2-(6,7-difluoro-1H-benzimidazol-1-yl)-N-{1-[4-(trifluoromethyl)phenyl]ethyl}aceta mide; vanilloid receptor 1 (VR1 or TRPV1) antagonist; antiinflammatory agent; neuropathic pain; arthritis, ischaemia, fibromyalgia, asthma, cough, inflammatory bowel disease, obesity |
| 07/17/2008 | US20080171745 Methods relating to the treatment of fibrosis |
| 07/17/2008 | US20080171692 Substituted amides |
| 07/17/2008 | US20080171091 Nanoparticulate compositions of immunosuppressive agents |